Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

China Radium-223 Safety and Effectiveness stuDy In Real World mCRPC paTients

NCT05301062 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05301062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05301062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
China Radium-223 Safety and Effectiveness stuDy In Real World mCRPC paTients
Lead sponsor
Bayer
Phase
Observational
Overall status
Terminated
Start date
September 15, 2022
Completion date
June 30, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, metastatic castration-resistant prostate cancer